Tumor-associated macrophages: from basic research to clinical application
Open accessAbstract
The fact that various immune cells, including macrophages, can be found in tumor tissues has long been known. With the introduction of concept that macrophages differentiate into a classically or alternatively activated phenotype, the role of tumor-associated macrophages (TAMs) is now beginning to be elucidated. TAMs act as "protumoral macrophages," contributing to disease progression. TAMs can promote initiation and metastasis of tumor cells, inhibit antitumor immune responses mediated by T cells, and stimulate tumor angiogenesis and subsequently tumor progression. As the relationship between TAMs and malignant tumors becomes clearer, TAMs are beginning to be seen as potential biomarkers for diagnosis and prognosis of cancers, as well as therapeutic targets in these cases. In this review, we will discuss the origin, polarization, and role of TAMs in human malignant tumors, as well as how TAMs can be used as diagnostic and prognostic biomarkers and therapeutic targets of cancer in clinics.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many factors in the tumor microenvironment, including cAMP, glucose competition, and oncogenic stress, can induce senescence of T cells, macrophages, natural killer cells, and dendritic cells.
“The role of immunosenescence in tumors is sophisticated: the many factors involved include cAMP, glucose competition, and oncogenic stress in the tumor microenvironment, which can induce the senescence of T cells, macrophages, natural killer cells, and dendritic cells.”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · see citing works
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · see citing works
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,178 · see citing works
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022 · see citing works
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,664 · see citing works
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647 · see citing works
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,399 · see citing works
DeNardo, D. G., Barreto, J., Andreu, P., Vásquez, L. J., Tawfik, D., Kolhatkar, N. S., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,340 · see citing works
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327 · see citing works
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Kim, S., Takahashi, H., Lin, W.-W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.-L., & Karin, M. (2009) · Nature · doi:10.1038/nature07623 · Cited by 1,100 · see citing works
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079 · see citing works
Mitchem, J. B., Brennan, D. J., Knolhoff, B. L., Belt, B. A., Zhu, Y., Sanford, D. E., Belaygorod, L., Carpenter, D. H., Collins, L. I., Piwnica-Worms, D. R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2731 · Cited by 943 · see citing works
The impact of the extracellular matrix on inflammation
Sorokin, L. M. (2010) · Nature reviews. Immunology · doi:10.1038/nri2852 · Cited by 911 · see citing works
Kuang, D., Zhao, Q., Peng, C., Xu, J., Zhang, J., Wu, C. Y., & Zheng, L. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 897 · see citing works
The effects of β-glucan on human immune and cancer cells
Chan, G., Chan, W. K., & Sze, D. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-25 · Cited by 866 · see citing works
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Germano, G., Frapolli, R., Belgiovine, C., Anselmo, A., Pesce, S., Liguori, M., Erba, E., Uboldi, S., Zucchetti, M., Pasqualini, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.008 · Cited by 863 · see citing works
Nywening, T. M., Wang‐Gillam, A., Sanford, D. E., Belt, B. A., Panni, R. Z., Cusworth, B. M., Toriola, A. T., Nieman, R., Worley, L. A., Yano, M., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00078-4 · Cited by 818 · see citing works
Kioi, M., Vogel, H. S., Schultz, G. M., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 778 · see citing works
Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.021 · Cited by 775 · see citing works
Gocheva, V., Wang, H., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T. A., & Joyce, J. A. (2010) · Genes & Development · doi:10.1101/gad.1874010 · Cited by 739 · see citing works
Song, M., Liu, T., Shi, C., Zhang, X., & Chen, X. S. (2015) · ACS Nano · doi:10.1021/acsnano.5b06779 · Cited by 664 · see citing works
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652 · see citing works
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Chen, J., Yao, Y., Gong, C., Yu, F., Su, S., Chen, J., Liu, B., Deng, H., Wang, F., Lin, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.006 · Cited by 645 · see citing works
Mazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639 · see citing works
Sanford, D. E., Belt, B. A., Panni, R. Z., Mayer, A., Deshpande, A. D., Carpenter, D. H., Mitchem, J. B., Plambeck-Suess, S. M., Worley, L. A., Goetz, B. D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0525 · Cited by 619 · see citing works
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S. R., Korets, L. V., Lam, J., Tawfik, D., DeNardo, D. G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.019 · Cited by 592 · see citing works
Chen, Y., Zhang, S., Wang, Q., & Zhang, X. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0408-0 · Cited by 481 · see citing works
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Damme, J. V., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 423 · see citing works
Pienta, K. J., Machiels, J.-P., Schrijvers, D. L. A. L., Alekseev, B. Y., Shkolnik, M. I., Crabb, S. J., Li, S., Seetharam, S., Puchalski, T. A., Takimoto, C. H. M., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9869-8 · Cited by 413 · see citing works
The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer
Greten, F. R. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.08.029 · Cited by 410 · see citing works
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Lu, T., Ramakrishnan, R., Altiok, S., Youn, J. I., Cheng, P., Celis, E., Писарев, В. М., Sherman, S., Sporn, M. B., & Gabrilovich, D. I. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45862 · Cited by 365 · see citing works
Ahn, G.-O., Tseng, D., Liao, C.-H., Dorie, M. J., Czechowicz, A., & Brown, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911378107 · Cited by 347 · see citing works
The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
Sánchez-Martı́n, L., Estecha, A., Samaniego, R., Sánchez‐Ramón, S., Vega, M. A., & Sánchez‐Mateos, P. (2010) · Blood · doi:10.1182/blood-2009-12-258186 · Cited by 322 · see citing works
Hussain, S. F., Kong, L.-Y., Jordan, J. T., Conrad, C. A., Madden, T. L., Fokt, I., Priebe, W., & Heimberger, A. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1243 · Cited by 317 · see citing works
Movahedi, K., Schoonooghe, S., Laoui, D., Houbracken, I., Waelput, W., Breckpot, K., Bouwens, L., Lahoutte, T., BAETSELIER, P. D., Raes, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2994 · Cited by 292 · see citing works
Allavena, P., Signorelli, M., Chieppa, M., Erba, E., Bianchi, G., Marchesi, F., Olimpio, C. O., Bonardi, C., Garbi, A., Lissoni, A. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4037 · Cited by 287 · see citing works
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Tang, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.024 · Cited by 276 · see citing works
Sandhu, S. K., Papadopoulos, K. P., Fong, P. C. C., Patnaik, A., Messiou, C., Olmos, D., Wang, G., Tromp, B. J., Puchalski, T. A., Balkwill, F. R., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2099-8 · Cited by 273 · see citing works
Circulating giant macrophages as a potential biomarker of solid tumors
Adams, D. L., Martin, S. S., Alpaugh, R. K., Charpentier, M. S., Tsai, S., Bergan, R. C., Ogden, I., Catàlona, W. J., Chumsri, S., Tang, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320198111 · Cited by 272 · see citing works
Wang, Y., Lin, Y., Qiao, S., An, H., Ma, Y., Qiao, Z., Rajapaksha, R. P. Y. J., & Wang, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.034 · Cited by 267 · see citing works
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
Pedroza‐González, A., Xu, K., Wu, T.-C., Aspord, C., Tindle, S., Marches, F., Gallegos, M., Burton, E. C., Savino, D. A., Hori, T., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102131 · Cited by 235 · see citing works
Tripathi, C., Tewari, B. N., Kanchan, R. K., Baghel, K. S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M. L. B., & Bhadauria, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2110 · Cited by 223 · see citing works
Braña, I., Calles, A., LoRusso, P. M., Yee, L., Puchalski, T. A., Seetharam, S., Zhong, B., de Boer, C. J., Tabernero, J. M., & Calvo, E. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0320-2 · Cited by 218 · see citing works
Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
Teng, F., Tian, W., Wang, Y., Zhang, Y., Guo, F., Zhao, J., Gao, C., & Xue, F. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0231-4 · Cited by 200 · see citing works
Self-citationLinde, N., Lederle, W., Depner, S., van Rooijen, N., Gutschalk, C. M., & Mueller, M. M. (2012) · The Journal of Pathology · doi:10.1002/path.3989 · Cited by 195 · see citing works
Is CD47 an innate immune checkpoint for tumor evasion?
Liu, X., Kwon, H., Li, Z., & Fu, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0381-z · Cited by 188 · see citing works
Yaddanapudi, K., Putty, K., Rendon, B. E., Lamont, G. J., Faughn, J., Satoskar, A. R., Lasnik, A. B., Eaton, J. W., & Mitchell, R. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201650 · Cited by 184 · see citing works
Shigeoka, M., Urakawa, N., Nakamura, T., et al. (2013) · Cancer Science · doi:10.1111/cas.12188 · Cited by 183 · see citing works
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
Raggi, C., Mousa, H. S., Correnti, M., Sica, A., & Invernizzi, P. (2015) · Oncogene · doi:10.1038/onc.2015.132 · Cited by 145 · see citing works
Kushner, B. H., Cheung, I. Y., Modak, S. I., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1012 · Cited by 145 · see citing works
Kong, L., Zhou, Y., Bu, H., Lv, T., Shi, Y., & Yang, J. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0412-1 · Cited by 143 · see citing works
Pyonteck, S. M., Gadea, B. B., Wang, H.-W., Gocheva, V., Hunter, K. E., Tang, L. H., & Joyce, J. A. (2011) · Oncogene · doi:10.1038/onc.2011.337 · Cited by 119 · see citing works
Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression
Ma, R., Ji, T., Chen, D., Dong, W., Zhang, Y., Yin, X., Ma, J., Liang, X., Zhang, Y., Shen, G., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1118599 · Cited by 118 · see citing works
Self-citationClinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study
Johnson, P., Challis, R., Chowdhury, F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2355 · Cited by 110 · see citing works
De, I., Steffen, M. D., Clark, P. A., Patros, C. J., Sokn, E., Bishop, S. M., Litscher, S. J., Maklakova, V. I., Kuo, J. S., Rodríguez, F. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2386 · Cited by 109 · see citing works
Chai, Z., Zhu, X., Ao, J., Wang, W., Gao, D., Kong, J., Zhang, N., Zhang, Y., Ye, B., Ma, D.-N., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0150-4 · Cited by 102 · see citing works
Self-citationCCR9 in cancer: oncogenic role and therapeutic targeting
Tu, Z., Xiao, R., Xiong, J., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0236-7 · Cited by 102 · see citing works
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Gordon, E. M., Sankhala, K. K., Chawla, N. S., & Chawla, S. P. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0344-3 · Cited by 97 · see citing works
Ambade, A., Satishchandran, A., Saha, B., Gyöngyösi, B., Lowe, P., Kodys, K., Catalano, D. E., & Szabó, G. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1221557 · Cited by 96 · see citing works
Finkernagel, F., Reinartz, S., Lieber, S., Adhikary, T., Wortmann, A., Hoffmann, N., Bieringer, T., Nist, A., Stiewe, T., Jansen, J. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12180 · Cited by 94 · see citing works
Li, Y., Wang, F., Wang, L., Huang, L. J., Wang, J., Zhang, B., & Zhang, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3547 · Cited by 93 · see citing works
Self-citationYamada, K., Uchiyama, A., Uehara, A., Perera, B., Ogino, S., Yokoyama, Y., Takeuchi, Y., Udey, M. C., Ishikawa, O., & Motegi, S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2812 · Cited by 87 · see citing works
Li, Y., Zheng, Y., Li, T., Wang, Q., Qian, J., Lu, Y., Zhang, M., Bi, E., Yang, M., Reu, F. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4523 · Cited by 83 · see citing works
Nandi, B., Shapiro, M., Samur, M., Pai, C., Frank, N. Y., Yoon, C. H., PRABHALA, R. H., Munshi, N. C., & Gold, J. S. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1189052 · Cited by 82 · see citing works
Thymosin α1 and cancer: action on immune effector and tumor target cells
Garaci, E., Pica, F., Serafino, A., Balestrieri, E., Matteucci, C., Moroni, G., Sorrentino, R., Zonfrillo, M., Pierimarchi, P., & Vallebona, P. S. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06697.x · Cited by 70 · see citing works
Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis
Tomita, T., Sakurai, Y., Ishibashi, S., & Maru, Y. (2011) · Oncogene · doi:10.1038/onc.2011.53 · Cited by 69 · see citing works
Kim, K.-J., Wen, X.-Y., Yang, H. K., Kim, W. H., & Kang, G. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144192 · Cited by 69 · see citing works
Wang, H., Shao, Q., Sun, J., Ma, C., Gao, W., Wang, Q., Zhao, L., & Qu, X. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1122157 · Cited by 69 · see citing works
Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer
Boström, M., Irjala, H., Mirtti, T., Taimen, P., Kauko, T., Ålgars, A., Jalkanen, S., & Boström, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133552 · Cited by 68 · see citing works
Zhao, P., Gao, D., Wang, Q., Song, B., Shao, Q., Sun, J., Ji, C., Li, X., Li, P., & Qu, X. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.108 · Cited by 63 · see citing works
Mota, J. M., Leite, C. A., de Souza, L. E. B., Melo, P. H., Nascimento, D. C., Wagatsuma, V. M. D. D., Temporal, J., Figueiredo, F., Noushmehr, H., Alves-Filho, J. C., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0170 · Cited by 63 · see citing works
Monocyte/macrophage‐derived soluble CD 163: a novel biomarker in multiple myeloma
Andersen, M. N., Abildgaard, N., Maniecki, M. B., Møller, H. J., & Andersen, N. F. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12296 · Cited by 62 · see citing works
Pulaski, H. L., Spahlinger, G., Silva, I. A., McLean, K., Kueck, A. S., Reynolds, R. K., Coukos, G., Conejo-Garcia, J. R., & Buckanovich, R. J. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-49 · Cited by 61 · see citing works
Xiao, G., Wang, X., Sheng, J., Lu, S., Yu, X., & Wu, J. D. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0110-z · Cited by 57 · see citing works
CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
Wang, F., Li, Y., Gao, Q., Huang, L. J., Wang, L., Wang, J., Wang, S., Zhang, B., & Zhang, Y. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1701-9 · Cited by 56 · see citing works
Self-citationSorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
Deng, Y., Liu, W., Lian, Z., Li, X., & Hou, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9438 · Cited by 54 · see citing works
Long non-coding RNAs in the regulation of myeloid cells
Tian, X., Tian, J., Tang, X., Ma, J., & Wang, S. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0333-7 · Cited by 49 · see citing works
Segal, N. H., Gada, P., Senzer, N. N., Gargano, M. A., Patchen, M. L., & Saltz, L. B. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.02.013 · Cited by 47 · see citing works
Cha, H.-R., Lee, J. H., Hensel, J. A., Sawant, A., Davis, B. H., Lee, C. M., Deshane, J. S., & Ponnazhagan, S. (2016) · The Prostate · doi:10.1002/pros.23155 · Cited by 41 · see citing works
Enhancement of DNA Vaccine Potency Against Legumain
Šmahel, M., Dušková, M., Poláková, I., et al. (2014) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000040 · Cited by 21 · see citing works
STAT of the union: Dynamics of distinct tumor‐associated macrophage subsets governed by STAT1
Overmeire, E. V., Laoui, D., Keirsse, J., Bonelli, S., Lahmar, Q., & Ginderachter, J. A. V. (2014) · European Journal of Immunology · doi:10.1002/eji.201444870 · Cited by 18 · see citing works
TAMable tumor-associated macrophages in response to innate RNA sensing
Seya, T., Shime, H., & Matsumoto, M. (2012) · OncoImmunology · doi:10.4161/onci.19894 · Cited by 18 · see citing works
Dysregulation of CXCL9 and reduced tumor growth in Egr-1 deficient mice
Caso, G., Barry, C. P., & Patejunas, G. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-7 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398 · see citing works
Immunosenescence: a key player in cancer development
Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00986-z · Cited by 510 · see citing works
Self-citationT Cell Dysfunction and Exhaustion in Cancer
Zhang, Z., Liu, S., Zhang, B., Qiao, L., Zhang, Y., & Zhang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00017 · Cited by 385 · see citing works
“Li and colleagues demonstrated that TAMs-secreted IL-10 promotes cancer stem cell-like properties and tumor growth in NSCLC; High levels of IL-10 are associated with a poor prognosis of NSCLC patients (Yang and Zhang, 2017).”
BackgroundSelf-citationTumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Li, C., Xu, X., Wei, S., Jiang, P., Xue, L., & Wang, J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001341 · Cited by 360 · see citing works
Wang, H., Tian, T., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168470 · Cited by 364 · see citing works
Understanding the tumor microenvironment for effective immunotherapy
Sadeghi Rad, H., Monkman, J., Warkiani, M. E., Ladwa, R., O'Byrne, K., Rezaei, N., & Kulasinghe, A. (2021) · Medicinal Research Reviews · doi:10.1002/med.21765 · Cited by 334 · see citing works
The role of cancer-derived microRNAs in cancer immune escape
Yi, M., Xu, L., Jiao, Y., Luo, S., Li, A., & Wu, K. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00848-8 · Cited by 221 · see citing works
Yang, L., Li, A., Lei, Q., & Zhang, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0804-8 · Cited by 215 · see citing works
Self-citationWang, D., Yang, L., Yue, D., Cao, L., Li, L., Wang, D., Ping, Y., Shen, Z., Zheng, Y., Wang, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.040 · Cited by 183 · see citing works
Self-citationKnox, T., Sahakian, E., Banik, D., Hadley, M., Palmer, E., Noonepalle, S., Kim, J., Powers, J., Gracia-Hernandez, M., Oliveira, V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42237-3 · Cited by 170 · see citing works
Wang, J., Man, G. C. W., Chan, T. H., Kwong, J., & Wang, C. C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.09.054 · Cited by 127 · see citing works
Yan, Z.-X., Li, L., Wang, W., OuYang, B.-S., Cheng, S., Wang, L., Wu, W., Xu, P.-P., Muftuoglu, M., Hao, M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0101 · Cited by 115 · see citing works
Alemohammad, H., Najafzadeh, B., Asadzadeh, Z., Baghbanzadeh, A., Ghorbaninezhad, F., Najafzadeh, A., Safarpour, H., Bernardini, R., Brunetti, O., Sonnessa, M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112516 · Cited by 92 · see citing works
Vahidian, F., Duijf, P. H. G., Safarzadeh, E., Derakhshani, A., Baghbanzadeh, A., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.004 · Cited by 75 · see citing works
Nam, S., Lee, A., Lim, J., & Lim, J.-S. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.201 · Cited by 68 · see citing works
Haave, H., Ljokjel, B., Lybak, H., Moe, S. E., Berge, J. E., Vintermyr, O. K., Helgeland, L., & Aarstad, H. J. (2022) · Biomedicines · doi:10.3390/biomedicines10102484 · Cited by 8 · see citing works
- Authors
- Yang, L., & Zhang, Y.
- Affiliations
- Zhengzhou University (CN)
- Corresponding author
- Zhang, Yi
- ORCID
- Zhang, Yi
- Venue
- Journal of Hematology & Oncology
- Published
- 2017-02-28
- Volume
- 10
- Issue
- 1
- Pages
- 58-58
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC5329931
- OpenAlex
- W2594615455
- Cited by
- 847
- References
- 83
- Citations by year
- 2026: 35 · 2025: 76 · 2024: 101 · 2023: 104 · 2022: 124 · 2021: 119 · 2020: 106 · 2019: 100 · 2018: 66 · 2017: 16
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81602024, 81171986)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, macrophage polarization, tumor progression, metastasis, antitumor immunity, tumor angiogenesis, tumor markers, prognostic factors, cancer therapy targets, macrophage origin
- MeSH terms
- Animals, Humans, Macrophages, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review